Disclosure as per Regulation 30 of SEBI(LODR) Regulation 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Ltd has informed BSE that two directors have resigned from the Board effective 21 January 2026. Mr. Rajender Parsad (DIN: 10871533), Additional & Non-Executive Director, stepped down citing personal and unavoidable reasons. Separately, Ms. Parul Agrawal (DIN: 11268580), Additional Non-Executive & Independent Director, also resigned on the same date for personal reasons. Both have confirmed there are no other material reasons behind their exits. The company filed these disclosures under Regulation 30 of SEBI LODR Regulations, 2015, as required for board changes.
This is a routine board-level change with no stated impact on business operations or financials. However, the company will need to fill the Independent Director seat to comply with SEBI's composition requirements. Shareholders should watch for announcements about new appointments.